At a glance
- Originator Nonindustrial source
- Class Antimalarials
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 15 Jun 2001 No-Development-Reported for Malaria in USA (Unknown route)
- 17 Jun 1997 New profile
- 17 Jun 1997 Preclinical development for Malaria in USA (Unknown route)